|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-6-13
|
|
pubmed:abstractText |
Plasma concentrations of high-density lipoprotein (HDL)-cholesterol correlate inversely with the incidence of myocardial infarction in humans. We investigated the effect of treatment with human apolipoprotein A-I (apoA-I), the principal protein of HDL, on plaque disruption in an animal model.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/APOA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiovascular Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 13,
http://linkedlifedata.com/resource/pubmed/chemical/Mmp13 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/S100 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/S100a4 protein, mouse
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1755-3245
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-44
|
|
pubmed:meshHeading |
pubmed-meshheading:21354994-Animals,
pubmed-meshheading:21354994-Apolipoprotein A-I,
pubmed-meshheading:21354994-Apolipoproteins E,
pubmed-meshheading:21354994-Atherosclerosis,
pubmed-meshheading:21354994-Brachiocephalic Trunk,
pubmed-meshheading:21354994-Cardiovascular Agents,
pubmed-meshheading:21354994-Cell Dedifferentiation,
pubmed-meshheading:21354994-Cholesterol, HDL,
pubmed-meshheading:21354994-Collagen,
pubmed-meshheading:21354994-Disease Models, Animal,
pubmed-meshheading:21354994-Fibrosis,
pubmed-meshheading:21354994-Humans,
pubmed-meshheading:21354994-Inflammation Mediators,
pubmed-meshheading:21354994-Macrophages,
pubmed-meshheading:21354994-Male,
pubmed-meshheading:21354994-Matrix Metalloproteinase 13,
pubmed-meshheading:21354994-Mice,
pubmed-meshheading:21354994-Mice, Inbred C57BL,
pubmed-meshheading:21354994-Mice, Knockout,
pubmed-meshheading:21354994-Muscle, Smooth, Vascular,
pubmed-meshheading:21354994-Myocytes, Smooth Muscle,
pubmed-meshheading:21354994-Plaque, Atherosclerotic,
pubmed-meshheading:21354994-Rupture, Spontaneous,
pubmed-meshheading:21354994-S100 Proteins
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
|
|
pubmed:affiliation |
The Heart Research Institute, 7 Eliza Street, Newtown NSW 2042, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
